Intervention group | Comparison group | Location of text (page/column/paragraph) | |||
Total number of women enrolled in study | |||||
For women enrolled in comparison of intervention/comparison | |||||
Number of women enrolled | |||||
Number of deaths | |||||
Number of women whose vital status was known | |||||
Time point at which deaths were recorded, for example, 1 year/5 years/end of study/not reported | |||||
Median time to death | |||||
Mean (SD) time to death | |||||
Number (%) of women with disease progression | |||||
Number of women whose disease was assessed | |||||
Time point at which disease progression was recorded, for example, 1 year/5 years/end of study/not reported | |||||
Median time to progression | |||||
Mean (SD) time to progression | |||||
QoL outcome State 'not reported' if not given |
Response | Relevant supporting text and location (page/column/paragraph) | |||
Validated scale Yes/No | |||||
Name of scale | |||||
Intervention group: Mean QoL at end of follow‐up SD of QoL at end of follow‐up Number of women assessed for QoL at end of follow‐up |
|||||
Comparison group: Mean QoL at end of follow‐up SD of QoL at end of follow‐up Number of women assessed for QoL at end of follow‐up |
|||||